- Home
- SHLT vs LVTX Comparison
SHLT vs LVTX Comparison
Compare SHLT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- LVTX
- Stock Information
- Founded
- SHLT 1987
- LVTX 2016
- Country
- SHLT Israel
- LVTX Netherlands
- Employees
- SHLT N/A
- LVTX N/A
- Industry
- SHLT Business Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- SHLT Consumer Discretionary
- LVTX Health Care
- Exchange
- SHLT Nasdaq
- LVTX Nasdaq
- Market Cap
- SHLT 39.3M
- LVTX 34.2M
- IPO Year
- SHLT N/A
- LVTX 2021
- Fundamental
- Price
- SHLT $2.05
- LVTX $1.16
- Analyst Decision
- SHLT
- LVTX Hold
- Analyst Count
- SHLT 0
- LVTX 3
- Target Price
- SHLT N/A
- LVTX $3.17
- AVG Volume (30 Days)
- SHLT 9.5K
- LVTX 57.7K
- Earning Date
- SHLT 04-24-2025
- LVTX 03-28-2025
- Dividend Yield
- SHLT N/A
- LVTX N/A
- EPS Growth
- SHLT N/A
- LVTX N/A
- EPS
- SHLT N/A
- LVTX N/A
- Revenue
- SHLT $55,939,000.00
- LVTX $11,982,000.00
- Revenue This Year
- SHLT N/A
- LVTX N/A
- Revenue Next Year
- SHLT N/A
- LVTX N/A
- P/E Ratio
- SHLT N/A
- LVTX N/A
- Revenue Growth
- SHLT N/A
- LVTX 77.01
- 52 Week Low
- SHLT $1.85
- LVTX $0.85
- 52 Week High
- SHLT $6.73
- LVTX $3.57
- Technical
- Relative Strength Index (RSI)
- SHLT 39.53
- LVTX 36.61
- Support Level
- SHLT $1.85
- LVTX $1.20
- Resistance Level
- SHLT $2.57
- LVTX $1.29
- Average True Range (ATR)
- SHLT 0.27
- LVTX 0.08
- MACD
- SHLT -0.03
- LVTX -0.03
- Stochastic Oscillator
- SHLT 26.67
- LVTX 0.00
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.